Tracking and Exploring the Source of Viral REbound

Analytical Treatment Interruption in HIV Positive Patients

NCT02590354 ·Status: COMPLETED ·Phase: NA

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

NCT03449706 ·Status: RECRUITING

Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals

NCT04097925 ·Status: COMPLETED ·Phase: PHASE2

Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy

NCT04448158 ·Status: COMPLETED

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment

NCT03137797 ·Status: COMPLETED

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

NCT00966160 ·Status: COMPLETED ·Phase: PHASE3

A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1

NCT01266902 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

NCT05349838 ·Status: COMPLETED ·Phase: PHASE3

Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

NCT00219986 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

NCT04133012 ·Status: COMPLETED ·Phase: NA

Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

NCT05303337 ·Status: RECRUITING

Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

NCT02337322 ·Status: UNKNOWN ·Phase: PHASE4

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

NCT06819176 ·Status: RECRUITING ·Phase: PHASE1

Biomarkers to Predict Time to Plasma HIV RNA Rebound

NCT03001128 ·Status: COMPLETED

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

NCT01440569 ·Status: COMPLETED ·Phase: PHASE3

TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants

NCT00980538 ·Status: COMPLETED ·Phase: PHASE3

Immuno-virological Evaluation of Persons Living With HIV (PLWH)

NCT05973825 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study of Recovery of Intestinal CD4+ and Th17 T Cells in HIV-infected Individuals on Short-term Antiretroviral Therapy

NCT02097381 ·Status: UNKNOWN ·Phase: NA

Impact of Raltegravir on the Viral Reservoirs

NCT01249560 ·Status: UNKNOWN

Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD

NCT04311944 ·Status: UNKNOWN ·Phase: NA

Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation

NCT02557997 ·Status: UNKNOWN

VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption

NCT02471326 ·Status: COMPLETED ·Phase: PHASE1

Effect of Dolutegravir Intensification on HIV-1 Reservoirs

NCT05351684 ·Status: COMPLETED ·Phase: PHASE2

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

NCT05219916 ·Status: TERMINATED ·Phase: NA

A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan Africa

NCT05373758 ·Status: RECRUITING ·Phase: NA